Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 1.00 |
| ▸ | NPC1 | O15118 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | MAOB | P27338 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.74 |
| ▸ | MEN1 | O00255 | 7/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.74 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.74 |
| ▸ | RELA | Q04206 | 2/20 | 0.74 |
| ▸ | PKM | P14618 | 1/20 | 0.74 |
| ▸ | TP53 | P04637 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4280503 | 1.00 | RAB9A (1.00) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL94748 | 0.88 | RAB9A (0.78) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL94747 | 0.88 | RAB9A (0.78) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL14772202 | 0.86 | RAB9A (0.76) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL8059583 | 0.86 | MAPT (0.74) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL8059586 | 0.86 | MAPT (0.74) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL20214182 | 0.84 | MAPT (0.75) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL6756826 | 0.84 | MAPT (0.71) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL6756641 | 0.84 | RAB9A (0.72) | RAB9ANPC1MAPTMAOBMAOA | |
| SCHEMBL6756640 | 0.84 | RAB9A (0.72) | RAB9ANPC1MAPTMAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099186-A1 | INHIBITORS OF VIRAL REPLICATION | INTERMUNE, INC. | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099186-A1 | INHIBITORS OF VIRAL REPLICATION | EIF2AK2, HAVCR2, RTF2 | RAB9A 3148/4885NPC1 680/4885MAPT 4203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.